Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125265181 | 12526518 | 1 | I | 20160613 | 20160705 | 20160705 | EXP | PHHY2016BR083785 | NOVARTIS | 0.00 | F | Y | 64.00000 | KG | 20160705 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125265181 | 12526518 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG (9 MG/ 5 CM2 PATCH), QD | Y | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 125265181 | 12526518 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 2 DF (PATCHES) (PATCH: 9 MG/5 CM2, 30 PATCHES), QD | Y | 22083 | 2 | DF | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 125265181 | 12526518 | 3 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG (9 MG/ 5 CM2 PATCH), QD | Y | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 125265181 | 12526518 | 4 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 125265181 | 12526518 | 5 | C | VYTORIN | EZETIMIBESIMVASTATIN | 1 | Oral | 1 DF, EVERY 3 DAYS | 0 | 1 | DF | TABLET | |||||||
| 125265181 | 12526518 | 6 | C | MOTILIUM//DOMPERIDONE MALEATE | 2 | Oral | 2 DF, QD | 0 | 2 | DF | TABLET | QD | |||||||
| 125265181 | 12526518 | 7 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 1 DF, QD | 0 | 1 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125265181 | 12526518 | 1 | Amnesia |
| 125265181 | 12526518 | 4 | Ischaemia |
| 125265181 | 12526518 | 5 | Product used for unknown indication |
| 125265181 | 12526518 | 6 | Product used for unknown indication |
| 125265181 | 12526518 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125265181 | 12526518 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125265181 | 12526518 | Concomitant disease aggravated | |
| 125265181 | 12526518 | Decreased appetite | |
| 125265181 | 12526518 | Depressed mood | |
| 125265181 | 12526518 | Depression | |
| 125265181 | 12526518 | Drug administration error | |
| 125265181 | 12526518 | Gait disturbance | |
| 125265181 | 12526518 | Hypersomnia | |
| 125265181 | 12526518 | Malaise | |
| 125265181 | 12526518 | Product use issue | |
| 125265181 | 12526518 | Tremor |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125265181 | 12526518 | 4 | 2011 | 0 | ||
| 125265181 | 12526518 | 5 | 2011 | 0 | ||
| 125265181 | 12526518 | 6 | 2011 | 0 | ||
| 125265181 | 12526518 | 7 | 2011 | 0 |